The only veterinary product approved in the whole of the EU, specifically for the treatment of ORT

ORT, a bacterial disease, forms an important part of the respiratory disease complex in turkeys and has a serious impact on health and productivity. The disease is transmitted vertically and horizontally. Most clinical outbreaks occur from 4 weeks of age and beyond in the fattening period. Outbreaks are associated with declining maternal immunity, the stress of movement and the demands of production.

ORT causes serious financial losses

Commercial operations frequently report increased death rates, retarded growth, reduction of feed conversion rates and lameness in older birds. This leads to increasing number of rejects at slaughter, and carcass quality suffers. Use of ineffective medications due to the wrong treatment being selected, adds to the cost.

Outstanding results have been achieved with Aivlosin® 625 mg/g Water Soluble Granules for the treatment of ORT in commercial turkey operations.

Outstanding performance and financials

Aivlosin ® 625 mg/g Water soluble granules have been shown to be effective with a significant reduction in mortality, recuperation of lost growth, and a great return on investment in a number of trials in the UK, Poland, Belgium and Morocco. The EU approved dosage for the medication of drinking water medication is 25mg Tylvalosin activity per kg bodyweight daily for 5 consecutive days. Treatment can be timed to coincide with the risk period on the particular production site, for example medication can be applied in the first 5 days of life or later on, at the grower stage, when clinical disease emerges in many commercial operations.

Aivlosin® has a short withdrawal time of two days, the water soluble granules are available in 40 and 400 gram sachets. Aivlosin® 625 mg/g Water Soluble Granules, is clearly a new and effective tool for veterinarians to treat ORT in the European turkey producing markets.